SONO TEK CORP — Form 8-K
Filed July 8, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
Sono-Tek reported Q1 FY2027 (ended May 31, 2026) net sales of $5.661M (up 10% YoY from $5.133M), with net income of $741K (up 53% from $485K) and diluted EPS of $0.05 (up from $0.03). Gross margin expanded to 57% from 52%, driven by medical market growth from $809K to $3.946M (388% increase) and higher-value system shipments. Backlog stood at $7.73M with $16.65M cash and no debt. Company guides flat-to-modest full-year FY2027 revenue growth despite strong 1H outlook.
Why this rating
Strong Q1 profitability improvement; medical revenue surge is real. However, company size ~$51M makes $5.7M quarterly revenue routine. FY guidance is flat—large orders timing risk acknowledged. Moderate near-term catalyst.
See more from July 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.